Leuthold Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-49,973
| Closed | -$7.96M | – | 200 |
|
2023
Q1 | $7.96M | Sell |
49,973
-1,021
| -2% | -$163K | 1.05% | 22 |
|
2022
Q4 | $8.24M | Sell |
50,994
-1,661
| -3% | -$268K | 1.11% | 20 |
|
2022
Q3 | $7.07M | Buy |
+52,655
| New | +$7.07M | 1.06% | 23 |
|
2021
Q2 | – | Sell |
-45,677
| Closed | -$4.94M | – | 183 |
|
2021
Q1 | $4.94M | Sell |
45,677
-4,139
| -8% | -$448K | 0.62% | 60 |
|
2020
Q4 | $5.34M | Sell |
49,816
-2,240
| -4% | -$240K | 0.7% | 48 |
|
2020
Q3 | $4.56M | Sell |
52,056
-1,029
| -2% | -$90.1K | 0.63% | 56 |
|
2020
Q2 | $5.21M | Sell |
53,085
-1,344
| -2% | -$132K | 0.78% | 45 |
|
2020
Q1 | $4.15M | Sell |
54,429
-4,923
| -8% | -$375K | 0.75% | 43 |
|
2019
Q4 | $5.26M | Buy |
+59,352
| New | +$5.26M | 0.68% | 61 |
|
2019
Q3 | – | Sell |
-53,674
| Closed | -$3.9M | – | 174 |
|
2019
Q2 | $3.9M | Sell |
53,674
-3,415
| -6% | -$248K | 0.5% | 83 |
|
2019
Q1 | $4.6M | Buy |
57,089
+22,097
| +63% | +$1.78M | 0.62% | 67 |
|
2018
Q4 | $3.23M | Sell |
34,992
-2,449
| -7% | -$226K | 0.46% | 83 |
|
2018
Q3 | $3.54M | Buy |
+37,441
| New | +$3.54M | 0.39% | 102 |
|
2018
Q1 | – | Sell |
-108,567
| Closed | -$10.5M | – | 192 |
|
2017
Q4 | $10.5M | Buy |
108,567
+17,389
| +19% | +$1.68M | 1.05% | 18 |
|
2017
Q3 | $8.1M | Sell |
91,178
-1,134
| -1% | -$101K | 0.82% | 31 |
|
2017
Q2 | $6.69M | Sell |
92,312
-3,216
| -3% | -$233K | 0.72% | 41 |
|
2017
Q1 | $6.23M | Sell |
95,528
-2,126
| -2% | -$139K | 0.67% | 47 |
|
2016
Q4 | $6.12M | Sell |
97,654
-7,623
| -7% | -$477K | 0.68% | 42 |
|
2016
Q3 | $6.64M | Buy |
+105,277
| New | +$6.64M | 0.7% | 49 |
|